.After antibody-drug conjugate (ADC) expert Seagen was marketed to Pfizer in 2014 for a monstrous $4...
.On the heels of a stage 3 win that fell short to blow away real estate investors, Ironwood Pharmace...
.Don't stop Monte Rosa Rehabs currently. The Boston-based biotech is actually enjoying after signing...
.Welcome to recently's Chutes & Ladders, our roundup of substantial management hirings, shootings...
.Commemorating his business's upsized going public (IPO), Septerna CEO Jeffrey Finer called the open...
.AbbVie has returned to the resource of its antipsychotic giant Vraylar in search of an additional s...
.GenSight Biologics is actually weeks off of lacking funds. Once again. The biotech merely possesses...
.Monopar Therapies is actually recovering a medicine from the scrap heap of AstraZeneca's rare healt...
.Along with brand-new data out on Arcus Biosciences' experimental HIF-2a prevention, one group of ex...
.After developing a genetics therapy partnership along with Dyno Rehabs in 2020, Roche is back for m...
.Lundbeck is slashing the book value of its own $250 million Abide Rehabs purchase in reaction to pe...
.The assimilation of real-world records (RWD) in to method usefulness as well as web site assortment...
.At this year's Fierce Biotech Top in Boston, our experts caught up with innovators in the biotech s...
.Merck & Co. is setting down $30 thousand upfront to purchase Yale spinout Modifi Biosciences, an...
.Alpha-9 Oncology has raised a $175 thousand collection C cycle to stake its own clinical-stage radi...
.Eye medicine maker Ocuphire Pharma is actually obtaining gene therapy programmer Opus Genetic makeu...
.Roche's persistent cough plan has actually faltered to a standstill. The drugmaker, which axed the ...
.Gilead Sciences as well as Merck & Co. have actually helped their once-weekly HIV combo therapy ...
.Lykos Therapies might possess dropped three-quarters of its team back the FDA's denial of its MDMA ...
.Septerna might be yet to make known "any kind of relevant professional information," however the bi...